← Back
$AKRO All transactions

Akero Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$177K

Shares

4,000

Price

$44

Filed

May 23

Insider

Name

Lamy Patrick

Title

Senior VP, Commercial Strategy

CIK

0001961273

Roles

Officer

Transaction Details

Transaction Date

2025-05-22

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

37,492

Footnotes

The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated January 6, 2025, previously adopted by the Reporting Person. | This option shall vest and become exercisable in 48 equal monthly installments, commencing on January 10, 2023.

Filing Info

Accession No.

0000950170-25-077131

Form Type

4

Issuer CIK

0001744659

Lamy Patrick's History

Date Ticker Type Value
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-07-01 AKRO $106K
2025-06-30 AKRO A $5K

Other Insiders at AKRO (90d)

No other insider activity at this issuer in the last 90 days.